Archives
-
EdU Imaging Kits (Cy3) for GBM S-Phase Assays
2026-10-01
EdU Imaging Kits (Cy3) convert DNA replication into a bright Cy3 signal for resolving how Nav1.6 and NHE1 perturb glioblastoma growth. This practical workflow combines microscopy or flow cytometry with pathway, migration, and apoptosis readouts to distinguish reduced S-phase entry from generalized toxicity.
-
Thioguanine Workflows for Epigenetic Cancer Assays
2026-10-01
Build more informative Thioguanine experiments by pairing viability and antiviral readouts with MIR9 methylation, DNMT1-related endpoints, and pathway-level validation. This workflow distinguishes evidence-backed benchmarks from practical starting conditions for cancer and EV71 models.
-
Cholecystokinin octapeptide ammonium: Assay Guide
2026-09-30
Use CCK-8 ammonium as a sulfation-sensitive, receptor-directed probe for neurobehavioral, survival, immune, and cardiac assays. This practical guide connects concentration planning, CNS workflow design, formulation control, and troubleshooting to evidence from a classic electroacupuncture-tolerance study.
-
Diethylmaleate as a Causal Redox Probe
2026-09-30
Diethylmaleate is an intracellular glutathione modulator that helps researchers test causal links between redox imbalance, GST activity, and toxicant sensitivity. This guide translates insect-resistance findings into practical assay design, controls, and interpretation strategies.
-
Renalase–PMCA4b/cAMP Control of Aldosterone
2026-09-29
A 2026 study identifies a PMCA4b-dependent cAMP/PKA pathway through which renalase increases aldosterone production in NCI-H295R adrenocortical cells. The findings connect renalase to steroidogenic gene regulation without increasing cell proliferation, while also providing a mechanistic framework for studying renalase in primary aldosteronism.
-
Nonselective β-Blockers and HCT Engraftment
2026-09-29
The reference study shows that nonselective β-adrenergic blockade can impair hematopoietic regeneration after transplantation, whereas β1-selective inhibition with metoprolol did not produce the same effect in the tested mouse and human settings. Its translational importance is the identification of post-transplant β-receptor selectivity, graft dose, and treatment context as variables that may influence engraftment and survival.
-
Pneumonectomy, SU5416, and Pulmonary Hypertension in Mice
2026-09-28
A 2024 short report tested whether pneumonectomy could replace hypoxia as the hemodynamic second hit in a mouse model combining vascular injury with SU5416 or monocrotaline pyrrole. In C57BL/6 mice, neither protocol produced severe, persistent pulmonary hypertension or greater pulmonary vascular remodeling than pneumonectomy alone, underscoring important species- and protocol-dependent limits.
-
Vitamin C Reduces Cochlear Cell Senescence via ROS/NF-κB
2026-09-28
A 2024 study found that Vitamin C improved several markers of D-galactose-induced senescence in HEI-OC1 cochlear cells, alongside reductions in reactive oxygen species and NF-κB activation. The results support a testable oxidative-stress mechanism for further age-related hearing loss research, while remaining preclinical and limited to a cell model.
-
Cytokine and Steroid Control of BIRC2 and BIRC3
2026-09-27
This study compares how inflammatory cytokines and glucocorticoids regulate BIRC2 and BIRC3 in pulmonary epithelial cell lines and primary bronchial epithelial cultures. Its central finding is a marked difference between the relatively stable BIRC2 protein and strongly inducible BIRC3, with implications for interpreting epithelial NF-κB signaling and steroid responses.
-
Resibufogenin Blocks NLRP3 in Atherosclerosis
2026-09-26
A 2025 study reports that resibufogenin reduced atherosclerotic plaque features in ApoE-/- mice and links these effects to inhibition of NLRP3 inflammasome assembly. Its combination of animal, cell-based, and binding analyses supports a mechanistic hypothesis while leaving questions about dose, safety, and clinical relevance for future work.
-
Firefly Luciferase mRNA: Assays and LNP Insights
2026-09-25
Use this bioluminescent reporter to compare mRNA delivery, translation, and cell-based assay conditions with a clear, quantifiable readout. Practical workflow guidance is paired with a careful look at how recent LNP vaccine research informs—without overpredicting—reporter assay design.
-
Annexin V-HF647/PI Apoptosis Kit in ESCC Research
2026-09-25
Learn how the Annexin V-HF647/PI Apoptosis Kit distinguishes phosphatidylserine exposure from loss of membrane integrity—and what those signals can and cannot reveal about cancer-cell death. An analysis of recent HOXC9–AKT/mTOR findings shows how to use apoptosis readouts without overinterpreting mechanism.
-
MDL 28170: Calpain Inhibitor Workflows
2026-09-24
Use MDL 28170 to test whether excessive cysteine-protease activity contributes to neuronal injury—not simply to label a result as calpain-specific. This workflow connects target engagement with BDNF/TrkB, synaptic, cell-survival, and behavioral readouts, while highlighting practical controls for interpreting partial rescue.
-
Pazopanib Hydrochloride: Read the Response, Not the Curve
2026-09-24
Pazopanib Hydrochloride (GW786034) is a multi-target inhibitor whose effects can look different depending on how a cancer assay defines response. Learn how to separate growth suppression from cell killing and design more interpretable preclinical studies.
-
Dacomitinib Workflows for ErbB Research
2026-09-23
Use Dacomitinib (PF-00299804) to connect ErbB receptor blockade with pathway, cell-cycle, and cell-death readouts in cancer models. This workflow also outlines a carefully bounded way to investigate mitochondrial ferroptosis biology without implying that Dacomitinib has been shown to regulate METTL17.